Infectious Diseases
Conference Coverage
Meningococcal vaccine shows benefit in STI prevention
“The duration of protective efficacy – a big thing in vaccines – is unknown. Still, this is really significant.”
From the Journals
COVID vs. flu: Which is deadlier?
People who were hospitalized with Omicron COVID-19 infections were 54% more likely to die, compared with people who were hospitalized with the flu...
Latest News
Zika virus still calls for preparedness and vaccine development
“There’s no antiviral that you can take for Zika. Until we have a vaccine, the key to controlling/preventing Zika is controlling the mosquitoes...
Latest News
Maternal infection in pregnancy ups risk for childhood leukemia?
Maternal infections during pregnancy may be associated with chromosomal and immunologic alterations in the fetus, the authors of the study...
From the Journals
COVID infection provides immunity equal to vaccination: Study
But protection against the BA.1 subvariant of Omicron was not as high.
From the Journals
Untreated COVID often involves relapse, clarifying antiviral rebound discussion
A new study’s findings offer a natural history of COVID-19 that will inform discussions and research concerning anti-viral therapy.
Feature
‘Infuriating’ prescription denial leaves patient without antiemetics
The patient was experiencing severe side effects from standard chemoradiation with weekly cisplatin.
From the Journals
COVID-19 shot appears to reduce diabetes risk, even after Omicron
Several studies conducted early in the pandemic suggested increased risks for both new-onset diabetes and cardiometabolic diseases following COVID...
News from the FDA/CDC
New challenge for docs: End of COVID federal public health emergency
The Biden administration intends to end by May 11 certain COVID-19 emergency measures used to aid in the response to the pandemic.
Latest News
NICU use up, birth weights down in babies of mothers with HCV
New findings surprised a study researcher since the adverse outcomes weren’t related to prematurity.
Latest News
Risk of infections low among kids receiving systemic meds for psoriasis, study finds
The analysis included 2,338 patients with psoriasis aged 17 years and younger who started new treatment with ustekinumab, etanercept, or...